MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
136 hedge funds and large institutions have $415M invested in Merrimack Pharmaceuticals, Inc. in 2016 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 40 increasing their positions, 42 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
60% less call options, than puts
Call options by funds: $1.17M | Put options by funds: $2.88M
Holders
136
Holding in Top 10
1
Calls
$1.17M
Puts
$2.88M
Top Buyers
| 1 | +$12.7M | |
| 2 | +$10.9M | |
| 3 | +$10.4M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$3.09M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.49M |
Top Sellers
| 1 | -$10.1M | |
| 2 | -$7.44M | |
| 3 | -$2.97M | |
| 4 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
-$2.62M |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$1.82M |